Condition

Nasopharyngeal Cancer clinical trials and research

• 12Clinical trials
• 9Countries

Newest Nasopharyngeal Cancer clinical trials

All recruiting trials (12)

• ImmunoPET imaging for solid tumors targeting Trop2

  This study is testing a new imaging method to see if it can help diagnose solid tumors like bladder and prostate cancer better than current methods.

  Recruiting Phase 2/3 RenJi Hospital · Shanghai · NCT06851663

• Combination of QL1706 and Chemoradiotherapy for Advanced Nasopharyngeal Cancer

  This study is testing if adding a new drug called QL1706 to standard chemotherapy and radiation can help people with advanced nasopharyngeal cancer live better and longer.

  Recruiting Phase 3 Sun Yat-sen University · Fuzhou, Fujian and 18 other locations · NCT06749899

• Induction chemotherapy followed by guided radiation for EBV-related nasopharyngeal cancer

  This study is testing a new way to treat EBV-related nasopharyngeal cancer by using a special type of chemotherapy followed by targeted radiation to see if it can reduce side effects while still being effective.

  Recruiting University of California, San Francisco · San Francisco, California · NCT06682442

• Combining Adebrelimab with Chemotherapy and Radiation for Advanced Nasopharyngeal Cancer

  This study is testing if adding a new drug called Adebrelimab to standard chemotherapy and radiation can help people with advanced nasopharyngeal cancer feel better and improve their chances of recovery.

  Recruiting at 4 sites Phase 2 Sun Yat-sen University · Xiamen, Fujian and 3 other locations · NCT06349889

• Using Nivolumab with chemotherapy for nasopharyngeal carcinoma in children and adults

  This study tests if adding the drug Nivolumab to regular chemotherapy can help children and adults with nasopharyngeal carcinoma respond better to treatment.

  Recruiting at 10 sites Phase 2 German Society for Pediatric Oncology and Hematology GPOH gGmbH · Aachen and 30 other locations · NCT06019130

• Evaluating BL-B01D1 for patients with advanced lung and solid tumors

  This study is testing a new treatment called BL-B01D1 to see if it is safe and effective for people with advanced lung cancer and other solid tumors.

  Recruiting at 37 sites Phase 1 SystImmune Inc. · Beverly Hills, California and 36 other locations · NCT05983432

• Modulation therapy for advanced nasopharyngeal cancer based on EBV DNA levels

  This study is testing if a personalized treatment plan based on blood tests for a virus can help people with advanced nasopharyngeal cancer live longer without their cancer getting worse after chemotherapy.

  Recruiting Phase 2 Fudan University · Shanghai, Shanghai Municipality · NCT05628922

• Induction gemcitabine and cisplatin with or without pembrolizumab and bevacizumab for locally advanced nasopharyngeal cancer

  This trial tests whether adding pembrolizumab and bevacizumab to induction gemcitabine and cisplatin improves metabolic complete response and survival in adults with locally advanced, EBV-positive nasopharyngeal cancer.

  Recruiting Phase 2 National University Hospital, Singapore · Singapore · NCT05305131

• Nivolumab treatment for nasopharyngeal cancer after platinum therapy

  This study is testing if Nivolumab, an immunotherapy drug, can help people with nasopharyngeal cancer who haven't responded to platinum chemotherapy.

  Recruiting at 4 sites Phase 2 Maria Sklodowska-Curie National Research Institute of Oncology · Bialystok and 3 other locations · NCT04875611

• Combining PD-1 treatment with chemotherapy and radiotherapy for high-risk nasopharyngeal cancer

  This study is testing if adding a new immune therapy to chemotherapy and radiotherapy can help people with high-risk nasopharyngeal cancer live longer and feel better.

  Recruiting at 3 sites Phase 3 Sun Yat-sen University · Guangzhou, Guangdong and 5 other locations · NCT04453826

• Identifying biomarkers for radiation sensitivity in cancer patients

  This study is trying to find out if certain blood and tissue markers can help predict how sensitive cancer patients are to radiation therapy, especially those who have had bad side effects.

  Recruiting National Cancer Centre, Singapore · Singapore · NCT04340024

• A resource for collecting cancer data and biospecimens

  This study is creating a resource to collect health information and samples from cancer patients and healthy individuals to help improve cancer prevention and treatment strategies.

  Recruiting at 42 sites University of Nebraska · Greenwood Village, Colorado and 41 other locations · NCT02012699

Related topics

Quick answers

How many Nasopharyngeal Cancer clinical trials are recruiting right now?

12, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 9 countries. The most sites are in China (5 trials), United States (3 trials), Singapore (2 trials), France (1 trial), Italy (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 5, Phase 3: 2, Phase 1: 1, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →